Rabo Ventures — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

ViAquaviaqua-t.comSep 2023✓ verified

ViAqua Therapeutics develops RNA-based solutions to treat diseases in aquaculture, specifically targeting viral pathogens like White Spot Shrimp Virus in shrimp through oral feed application.

AgTechAI & Machine LearningBiotechFoodTech

Shai Ufaz(CEO & Co-Founder)inShai Einbinder(Co-Founder)in

Co-investorsS2G Investments Israel Innovation Authority Rabo Corporate Venturing Trendlines Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.